Huiying Medical Technology Co.,Ltd.

Huiying Medical Technology Co.,Ltd. is a national high-tech artificial intelligence company in the medical imaging filed, focusing on computer vision and deep learning. The company was founded in 2015 and is headquartered in Beijing, with branches in Silicon Valley, USA, Hong Kong, Suzhou, Xiamen, and Guangzhou. Huiying Medical Technology is a leader in industrial technology and commercialization and has formed multiple product lines from scientific research to clinical applications. The company has realized the full process coverage with AI, including AI screening, diagnosis, and the full cycle of prognosis prediction, making it the only company based on multi-model, full imaging data chain in this field. Huiying Medical Technology has established collaborations with more than 800 top hospitals for scientific research and clinical applications, such as Chinese PLA General Hospital, Peking Union Medical College Hospital, Beijing Friendship Hospital, Cancer Hospital Chinese Academy of Medical Sciences, Beijing Cancer Hospital, Zhengzhou University Third Hospital, and Ordos Partnership Medical Center. The company provides a full solution for patient-oriented clinical diagnosis treatment and medical data analysis, focusing on the digitalization, mobilization, and intelligence of medical imaging. In November 16, 2020, Huiying Medical Technology secured a CNY100.00M Series C investment, with the participation of key investors including BlueRun Ventures, CDH Investments, Delta Capital, Sinopharm Capital, and Shougang Fund. The company has also set up strategic cooperation with Tsinghua University, Stanford University, China Unicom, Tencent, Intel, and Alibaba, aiming to become a world-class and respectable unicorn company in the industry.